Activist Saba Capital Files Definitive Proxy to Elect Director, Citing Fund's Trading Discount

summarizeSummary

Activist investor Saba Capital, holding a 9.76% stake, has filed its definitive proxy statement to elect Paul Kazarian to the board, aiming to address the Fund's persistent trading discount to net asset value.

check_boxKey Events

• Activist Proxy Solicitation

  Saba Capital has filed its definitive proxy statement to solicit shareholder votes for its nominee, Paul Kazarian, to the Board of Directors.

• Nominee for Board

  Paul Kazarian, a Partner and Closed-End Fund Portfolio Manager at Saba Capital, is nominated as a Class II director.

• Addressing Trading Discount

  Saba's primary objective is to elect a director who will bring fresh ideas to address the Fund's trading discount to net asset value, which was -7.91% as of April 29, 2026.

• Significant Shareholder Stake

  Saba Capital beneficially owns 6,076,820 Common Shares, representing 9.76% of the outstanding Common Shares.

auto_awesomeAnalysis

This filing marks a critical development in the ongoing proxy contest, as activist investor Saba Capital formally presents its case and nominee to shareholders. Saba, a significant shareholder with a 9.76% stake, is seeking board representation to address the Fund's trading discount to net asset value, which it views as a sign of underperformance. The election of Saba's nominee, Paul Kazarian, could introduce new perspectives to the board and potentially lead to strategic changes aimed at enhancing shareholder value. Investors should closely monitor the upcoming annual meeting on June 11, 2026, as the outcome will determine the extent of activist influence on the Fund's governance and future direction.